Academic literature on the topic 'Ulcers'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Ulcers.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Ulcers"
Maksymchuk, D., V. Mamchych, and V. Maksymchuk. "Surgical treatment of complicated duodenal ulcers with different variants of their localization." Journal of Education, Health and Sport 11, no. 9 (September 30, 2021): 773–80. http://dx.doi.org/10.12775/jehs.2021.11.09.093.
Full textPeetsalu, Margot, Ülle Kirsimägi, and Ants Peetsalu. "Giant Prepyloric Ulcer Haemorrhage: Patient Characteristics, Treatment, and Outcome in 2003–2012." Ulcers 2014 (April 10, 2014): 1–5. http://dx.doi.org/10.1155/2014/326065.
Full textKamada, Tomoari, Kiichi Satoh, Toshiyuki Itoh, Masanori Ito, Junichi Iwamoto, Tadayoshi Okimoto, Takeshi Kanno, et al. "Evidence-based clinical practice guidelines for peptic ulcer disease 2020." Journal of Gastroenterology 56, no. 4 (February 23, 2021): 303–22. http://dx.doi.org/10.1007/s00535-021-01769-0.
Full textWakiya, R., Y. Ushio, K. Ueeda, H. Shimada, S. Nakashima, M. Kato, T. Miyagi, et al. "POS1362 THE EFFICACY AND CYTOKINE PROFILES DURING TREATMENT WITH APREMILAST IN PATIENTS WITH BEHÇET ‘S DISEASE." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1020.1–1020. http://dx.doi.org/10.1136/annrheumdis-2022-eular.4181.
Full textRasajnam, Neethu, Sreejith Kalathummarathu, Shehadad Kammili, and Sreedevi Menon. "Clinical Outcome of Chronic Leg and Foot Ulcers Treated with Autologous Platelet Rich Fibrin." Journal of Evolution of Medical and Dental Sciences 11, no. 1 (January 13, 2022): 33–38. http://dx.doi.org/10.14260/jemds/2022/7.
Full textKulkarni, S. R., M. S. Gohel, M. R. Whyman, and K. R. Poskitt. "Significance of limb trauma as an initiating factor in chronic leg ulceration." Phlebology: The Journal of Venous Disease 23, no. 3 (June 2008): 130–36. http://dx.doi.org/10.1258/phleb.2007.007024.
Full textLaborde, James M. "Midfoot Ulcers Treated with Gastrocnemius-Soleus Recession." Foot & Ankle International 30, no. 9 (September 2009): 842–46. http://dx.doi.org/10.3113/fai.2009.0842.
Full textCheng, Hsiu-Chi, Hsiao-Bai Yang, Wei-Lun Chang, Wei-Ying Chen, Yi-Chun Yeh, and Bor-Shyang Sheu. "Expressions of MMPs and TIMP-1 in Gastric Ulcers May DifferentiateH. pylori-Infected from NSAID-Related Ulcers." Scientific World Journal 2012 (2012): 1–9. http://dx.doi.org/10.1100/2012/539316.
Full textIamandii, Inga, Abram Beatrice Kouassi, Davide Simonazzi, Cristina Marchesi, Marco Vinceti, and Tommaso Filippini. "Healing Time of Skin Ulcers in Homecare Residents in the Province of Reggio Emilia, Northern Italy." Life 12, no. 12 (November 28, 2022): 1989. http://dx.doi.org/10.3390/life12121989.
Full textLindholm, C., M. Bjellerup, O. B. Christensen, and B. Zederfeldt. "Leg and foot ulcers. Nursing care in Malmö, Sweden." Acta Dermato-Venereologica 72, no. 3 (January 1, 1992): 224–26. http://dx.doi.org/10.2340/0001555572224226.
Full textDissertations / Theses on the topic "Ulcers"
Obogo, E., and E. Bassey. "Perforated duodenal ulcers associated with other complications of peptic ulcer disease." Thesis, Видавництво СумДУ, 2012. http://essuir.sumdu.edu.ua/handle/123456789/27515.
Full textAdriaans, Beverley. "The aetiology and pathogenesis of tropical ulcer." Master's thesis, University of Cape Town, 1988. http://hdl.handle.net/11427/25758.
Full textLoots, Miriam Alfonsa Maria. "Wound healing in diabetic ulcers." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2002. http://dare.uva.nl/document/66897.
Full textSahin, Birnur. "DEVA : Treating Chroinic Leg Ulcers." Thesis, Umeå universitet, Designhögskolan vid Umeå universitet, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-172613.
Full textAngelis, Célio Damacena de [UNESP]. "Avaliação da proteção gástrica e duodenal do monoterpeno nerol em roedores." Universidade Estadual Paulista (UNESP), 2012. http://hdl.handle.net/11449/91622.
Full textCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Este projeto se propôs a avaliar a ação farmacológica do nerol na prevenção de úlcera péptica. Nerol na dose de 60 mg/Kg por via oral exerceu proteção contra lesão gástrica induzida por etanol e por droga anti-inflamatória não esteróide (DAINE) em ratos, mas não protegeu contra úlcera duodenal induzida por cisteamina. Experimentos foram realizados para a elucidação dos mecanismos ação e verificou-se que a proteção exercida pelo Nerol não é por bloqueio dos radicais livres, por redução da secreção gástrica ou por aumento de muco, sua ação também não ocorre por formação de barreira mecânica. Verificou-se, contudo, que houve redução da motilidade gastrointestinal, o que pode ser um indicativo de redução do esvaziamento gástrico, o que contribui para o efeito gastroprotetor. A redução da motilidade gastrointestinal assim como a redução do acúmulo intestinal exercido pelo nerol foi revertida pela administração de naloxona (antagonista de receptores opióides), indicando, portanto, o envolvimento destes receptores. Através do bloqueio de fatores protetores da mucosa gástrica, verificou-se que a gastroproteção exercida pelo nerol é independente da via do óxido nítrico, de prostaglandinas e dos receptores mu opióides, porém, é dependente de compostos sulfidrílicos. Mostrou-se através da quantificação dos níveis de glutationa (GSH) e da atividade da enzima mieloperoxidase (MPO) que o tratamento com nerol mantém os níveis de compostos sulfidrílicos não-protéicos e reduz a infiltração de neutrófilos na mucosa gástrica em animais com lesão gástrica induzida por etanol. A administração aguda de nerol (doses de 60, 300, 600, 1250, 2500 ou 5000 mg/Kg) não provocou mortes nem alterações significantes nos parâmetros comportamentais até a dose de 600 mg/Kg. Neste trabalho portanto, ficou...
The present project proposed to evaluate the pharmacologic action of nerol in the prevection of peptic ulcer. It was seen that 60 mg/kg (p.o.) of nerol prevented gastric lesions induced by ethanol and no steroidal anti-inflammatory drugs (NSAID) in rats, however nerol did not have protected duodenal mucosa against cysteamine. Assays were performed to elucidation of the mechanisms of action and it was found that protection exerted by Nerol does not by block of free radicals, nor decrease gastric acid secretion nor increase mucus, its action is not by create a mechanical barrier. However It was found that nerol reduced gastrointestinal motility, this might be an indicative of slower gastric emptying that contribute to the gastric protective effect. Reduction of gastrointestinal motility, as well as the reduction of intestinal accumulation exerted by nerol was reverted by naloxone administration (antagonist of opioid receptors), therefore indicating involvement of the cited receptors. By blocking protective factors of gastric mucosa, it was verified that nerol’s gastroprotective effect does not involve nitric oxide, prostaglandin nor mu opioid receptors, but is dependent of sulfhydryl compounds. It was shown by quantifying glutathione levels (GSH) and myeloperoxidase (MPO) action that treatment with nerol keeps the levels of non proteic sulfhydryl compounds and decreases the neutrophil infiltration into the gastric mucosa in animals with ethanol-induced gastric damage. Acute administration of nerol (60, 300, 600, 1250, 2500 and 5000 mg/Kg) presented no deaths, neither significant behavior changes to doses of 60, 300 and 600 mg/kg. In this work, nerol showed a gastroprotective effect against ethanol- and indomethacin-induced lesions, and the depence of sulfhydryl compounds. The involvement of opioid receptors and the gastrointestinal... (Complete abstract click electronic access below)
Silva, Laísa Pinheiro da [UNESP]. "Avaliação dos mecanismos de ação envolvidos nas atividades antiulcerogênica e cicatrizante do extrato etanólico obtido a partir das folhas de Terminalia catappa L. (COMBRETACEAE)." Universidade Estadual Paulista (UNESP), 2012. http://hdl.handle.net/11449/91639.
Full textCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Terminalia catappa Linn é uma espécie comumente utilizada para arborização nas regiões tropical e subtropical. Essa espécie é também utilizada, em países da Ásia, como Taiwan, Índia, Flipinas e Indonésia, para tratamento de distúrbios hepáticos e do trato gastrointestinal. A literatura aponta que seus constituintes encontrados nos extratos polares das folhas são principalmente compostos polifenólicos, em especial os taninos. A partir desses dados e da ausência de registros na literatura sobre a ação antiulcerogênica desta espécie foram realizados estudos para avaliação dessa atividade das frações e caracterização da fração mais ativa, assim como a determinação do mecanismo de ação gastroprotetor e cicatrizante da fração ativa. A partir do extrato etanólico bruto das folhas, que em estudo anterior realizado pelo grupo demonstrou atividade gastroprotetora, antisecretória e cicatrizante, foi feita a partição com três solventes de diferentes polaridades (hexano, acetato de etila e metanol/água). As três frações oriundas destas extrações apresentaram ação gastroprotetora em úlcera induzida por etanol absoluto, porém a fração mais efetiva foi a aquosa na dose de 25 mg/Kg, selecionada para caracterizar os mecanismos de ação envolvidos na ação antiulcerogênica como: óxido nítrico (NO), prostaglandinas (PG), aumento de muco e atividade antioxidante por meio da manutenção dos níveis de glutationa e redução da atividade da enzima mieloperoxidase (MPO). Não foram observadas a participação dos grupamentos sulfidrila e ação antisecretória. Foi constatada atividade cicatrizante tanto com 7 como com 14 dias de tratamento, consecutivos, da fração aquosa. Durante o tratamento com a partição aquosa ocorreu uma...
Terminalia catappa Linn is a specie commonly used for afforestation in tropical and subtropical regions. It is used, in Asian countries, as Taiwan, India, Filipines and Indonesia, for treatment of hepatic and gastrointestinal disorders. Studies point to poliphenols as main components of polar leaves extract, specially the tannins. Based on this and in the lack of information about a possible gastroprotective action of this specie, studies for avaliation of this activity were done with fractions of the ethanolic extract, and gastroprotective action mechanisms were characterized in the most active fraction. A previous study done by our group showed the ethanolic extract as gastroprotective, antisecretory and healing. The ethanol extract were partitioned with three different solvents, hexane, etil acetate and methanol/water. The three fractions showed gastroprotective action in the model of ulcer induced by ethanol, but the most effective was aquous fraction in a dose of 25 mg/Kg, which was the one selected to the characterization of the mechanisms involved in the antiulcerogenic activity as: nitric oxide (NO), prostaglandins (PG), mucus and antioxidant activity by maintenance of glutathione levels and reduction in mieloperoxidase (MPO) enzyme activity. No participation of sulphidryls compounds and antisecretory activity were detected. The aquous fraction also showed healing action in the treatment for 7 and 14 days, in both of them was detected a down-regulation in metalloproteinase-2 (MPP-2). In a subchronic toxicity avaliation, the aquous fraction in 25 mg/Kg doesn´t presented a toxic potential. In the model of gastric ulcer induced by indomethacin, the aquous fraction in a dose of 50 mg/Kg, aggravated the lesions, which showed an evidence for antiinflamatory activity, it was confirmed in Formalin test and ear edema induced by... (Complete abstract click electronic access below)
Silva, Laísa Pinheiro da. "Avaliação dos mecanismos de ação envolvidos nas atividades antiulcerogênica e cicatrizante do extrato etanólico obtido a partir das folhas de Terminalia catappa L. (COMBRETACEAE) /." Botucatu : [s.n.], 2012. http://hdl.handle.net/11449/91639.
Full textBanca: Wagner Villegas
Banca: Walter Toma
Resumo: Terminalia catappa Linn é uma espécie comumente utilizada para arborização nas regiões tropical e subtropical. Essa espécie é também utilizada, em países da Ásia, como Taiwan, Índia, Flipinas e Indonésia, para tratamento de distúrbios hepáticos e do trato gastrointestinal. A literatura aponta que seus constituintes encontrados nos extratos polares das folhas são principalmente compostos polifenólicos, em especial os taninos. A partir desses dados e da ausência de registros na literatura sobre a ação antiulcerogênica desta espécie foram realizados estudos para avaliação dessa atividade das frações e caracterização da fração mais ativa, assim como a determinação do mecanismo de ação gastroprotetor e cicatrizante da fração ativa. A partir do extrato etanólico bruto das folhas, que em estudo anterior realizado pelo grupo demonstrou atividade gastroprotetora, antisecretória e cicatrizante, foi feita a partição com três solventes de diferentes polaridades (hexano, acetato de etila e metanol/água). As três frações oriundas destas extrações apresentaram ação gastroprotetora em úlcera induzida por etanol absoluto, porém a fração mais efetiva foi a aquosa na dose de 25 mg/Kg, selecionada para caracterizar os mecanismos de ação envolvidos na ação antiulcerogênica como: óxido nítrico (NO), prostaglandinas (PG), aumento de muco e atividade antioxidante por meio da manutenção dos níveis de glutationa e redução da atividade da enzima mieloperoxidase (MPO). Não foram observadas a participação dos grupamentos sulfidrila e ação antisecretória. Foi constatada atividade cicatrizante tanto com 7 como com 14 dias de tratamento, consecutivos, da fração aquosa. Durante o tratamento com a partição aquosa ocorreu uma... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: Terminalia catappa Linn is a specie commonly used for afforestation in tropical and subtropical regions. It is used, in Asian countries, as Taiwan, India, Filipines and Indonesia, for treatment of hepatic and gastrointestinal disorders. Studies point to poliphenols as main components of polar leaves extract, specially the tannins. Based on this and in the lack of information about a possible gastroprotective action of this specie, studies for avaliation of this activity were done with fractions of the ethanolic extract, and gastroprotective action mechanisms were characterized in the most active fraction. A previous study done by our group showed the ethanolic extract as gastroprotective, antisecretory and healing. The ethanol extract were partitioned with three different solvents, hexane, etil acetate and methanol/water. The three fractions showed gastroprotective action in the model of ulcer induced by ethanol, but the most effective was aquous fraction in a dose of 25 mg/Kg, which was the one selected to the characterization of the mechanisms involved in the antiulcerogenic activity as: nitric oxide (NO), prostaglandins (PG), mucus and antioxidant activity by maintenance of glutathione levels and reduction in mieloperoxidase (MPO) enzyme activity. No participation of sulphidryls compounds and antisecretory activity were detected. The aquous fraction also showed healing action in the treatment for 7 and 14 days, in both of them was detected a down-regulation in metalloproteinase-2 (MPP-2). In a subchronic toxicity avaliation, the aquous fraction in 25 mg/Kg doesn't presented a toxic potential. In the model of gastric ulcer induced by indomethacin, the aquous fraction in a dose of 50 mg/Kg, aggravated the lesions, which showed an evidence for antiinflamatory activity, it was confirmed in Formalin test and ear edema induced by... (Complete abstract click electronic access below)
Mestre
Angelis, Célio Damacena de. "Avaliação da proteção gástrica e duodenal do monoterpeno nerol em roedores /." Botucatu, 2012. http://hdl.handle.net/11449/91622.
Full textBanca: Elfriede Marianne Bacchi
Banca: Luiz Claudio Di Stasi
Resumo: Este projeto se propôs a avaliar a ação farmacológica do nerol na prevenção de úlcera péptica. Nerol na dose de 60 mg/Kg por via oral exerceu proteção contra lesão gástrica induzida por etanol e por droga anti-inflamatória não esteróide (DAINE) em ratos, mas não protegeu contra úlcera duodenal induzida por cisteamina. Experimentos foram realizados para a elucidação dos mecanismos ação e verificou-se que a proteção exercida pelo Nerol não é por bloqueio dos radicais livres, por redução da secreção gástrica ou por aumento de muco, sua ação também não ocorre por formação de barreira mecânica. Verificou-se, contudo, que houve redução da motilidade gastrointestinal, o que pode ser um indicativo de redução do esvaziamento gástrico, o que contribui para o efeito gastroprotetor. A redução da motilidade gastrointestinal assim como a redução do acúmulo intestinal exercido pelo nerol foi revertida pela administração de naloxona (antagonista de receptores opióides), indicando, portanto, o envolvimento destes receptores. Através do bloqueio de fatores protetores da mucosa gástrica, verificou-se que a gastroproteção exercida pelo nerol é independente da via do óxido nítrico, de prostaglandinas e dos receptores mu opióides, porém, é dependente de compostos sulfidrílicos. Mostrou-se através da quantificação dos níveis de glutationa (GSH) e da atividade da enzima mieloperoxidase (MPO) que o tratamento com nerol mantém os níveis de compostos sulfidrílicos não-protéicos e reduz a infiltração de neutrófilos na mucosa gástrica em animais com lesão gástrica induzida por etanol. A administração aguda de nerol (doses de 60, 300, 600, 1250, 2500 ou 5000 mg/Kg) não provocou mortes nem alterações significantes nos parâmetros comportamentais até a dose de 600 mg/Kg. Neste trabalho portanto, ficou... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: The present project proposed to evaluate the pharmacologic action of nerol in the prevection of peptic ulcer. It was seen that 60 mg/kg (p.o.) of nerol prevented gastric lesions induced by ethanol and no steroidal anti-inflammatory drugs (NSAID) in rats, however nerol did not have protected duodenal mucosa against cysteamine. Assays were performed to elucidation of the mechanisms of action and it was found that protection exerted by Nerol does not by block of free radicals, nor decrease gastric acid secretion nor increase mucus, its action is not by create a mechanical barrier. However It was found that nerol reduced gastrointestinal motility, this might be an indicative of slower gastric emptying that contribute to the gastric protective effect. Reduction of gastrointestinal motility, as well as the reduction of intestinal accumulation exerted by nerol was reverted by naloxone administration (antagonist of opioid receptors), therefore indicating involvement of the cited receptors. By blocking protective factors of gastric mucosa, it was verified that nerol's gastroprotective effect does not involve nitric oxide, prostaglandin nor mu opioid receptors, but is dependent of sulfhydryl compounds. It was shown by quantifying glutathione levels (GSH) and myeloperoxidase (MPO) action that treatment with nerol keeps the levels of non proteic sulfhydryl compounds and decreases the neutrophil infiltration into the gastric mucosa in animals with ethanol-induced gastric damage. Acute administration of nerol (60, 300, 600, 1250, 2500 and 5000 mg/Kg) presented no deaths, neither significant behavior changes to doses of 60, 300 and 600 mg/kg. In this work, nerol showed a gastroprotective effect against ethanol- and indomethacin-induced lesions, and the depence of sulfhydryl compounds. The involvement of opioid receptors and the gastrointestinal... (Complete abstract click electronic access below)
Mestre
Debacker, Martine M. J. "L'ulcère de Buruli dans un centre de santé rural au Bénin." Doctoral thesis, Universite Libre de Bruxelles, 2005. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/211042.
Full textUne première publication porte sur 1700 cas consécutifs admis au CSNG entre 1997 et 2001. Ces données nous ont permis d’illustrer l’évolution du nombre des cas d’UB au cours des années, par département et par sous-préfecture. Le nombre de patients UB qui se présentent au centre est fonction de différents facteurs comme par exemple l’ouverture d’autres centres de traitement, l’organisation de campagnes d’information sur l’UB mais aussi de changements dans l’environnement. Au niveau des formes de la maladie, nous avons montré que les formes non ulcérées sont aussi fréquentes que les formes ulcérées. La forme de la maladie est liée au délai à consulter le CSNG. Les atteintes osseuses sont fréquentes et sont présentes chez plus de 13% des cas. Au fil des années, le délai à consulter le CSNG ainsi que la durée de l’hospitalisation ont été fortement réduits, passant de 4 mois à 1 mois dans le premier cas et de 9 mois à 1 mois en ce qui concerne l’hospitalisation. Les personnes ressources à cibler lors des campagnes de sensibilisation sur la maladie ont été identifiées. Il s’agit des anciens malades, qui dans 68% des cas, réfèrent les nouveaux malades au CSNG.
Une deuxième publication, portant sur la même période, nous a permis de mettre en évidence pour la première fois des taux d’UB élevés chez les sujets de 60 ans et plus, probablement du fait d’une diminution de leur immunité. Chez les 60 ans et plus, les hommes sont plus à risque de développer un UB que les femmes. Par contre aucune différence dans le risque d’UB en fonction du sexe n’est trouvée chez les moins de 60 ans. Les lésions d’UB prédominent au niveau des membres inférieurs pour tous les groupes d’âge. Du fait de leur petite stature, les enfants ont une répartition des lésions qui touchent tout le corps. Chez les adultes, les femmes présentent plus de lésions que les hommes au niveau de la tête, du cou et du tronc. Les sujets de moins de 15 ans développent souvent des lésions multifocales, associées à des atteintes osseuses. Ces atteintes osseuses constituent les formes graves de la maladie.
Notre troisième publication porte sur le suivi des malades au niveau des villages, entre mars 2000 et février 2001, afin de déterminer les taux de récurrences de l’UB. Le taux de récurrence de la maladie est faible (6.1%) pour un temps de suivi des malades allant jusqu’à 7 ans. La majorité des malades soignés au CSNG étaient en bonne santé. Nous n’avons néanmoins pu retrouver qu’un nombre limité de malades.
Dans notre quatrième publication, nous avons pu mettre en évidence le développement d’un UB sur le site d’une morsure humaine. La surface de la peau du malade a pu être contaminée par M. ulcerans et la morsure (= traumatisme) a occasionné l’entrée de M. ulcerans dans le derme. Une autre explication plausible est que la morsure ait réactivé un foyer latent de M. ulcerans au niveau du site de la morsure.
Notre base de données nous a également permis de contribuer à d’autres études, notamment celles sur l’influence du BCG et de la schistosomiase sur l’UB. Dans les deux cas, nous trouvons une association significative avec les formes graves de l’UB, l’absence de vaccination BCG et la schistosomiase favorisant le développement de formes osseuses. Aucun lien n’a pu être établi entre la présence ou l’absence de l’infection à Schistosoma haematobium et l’UB.
Dans la dernière partie de notre travail, nous nous sommes attachés à l’étude de quelques facteurs de risque de l’UB. Nous avons montré que l’UB est essentiellement associé à l’âge, le lieu de résidence et le type d’eau utilisé. Pour les sujets de 5 ans et plus, le risque d’UB est plus élevé chez les sujets vaccinés à la naissance avec le BCG. L’analyse par strate d’âge des sujets âgés de 5 ans et plus, nous a permis de voir que dans le groupe des 50 ans et plus l’influence du type d’eau utilisé est moindre que dans les autres groupes d’âge, laissant envisager qu’un autre facteur entre en jeu :une réactivation de la maladie à la faveur d’une baisse d’immunité.
Notre étude démontre que la prise en charge de l’UB doit être pluridisciplinaire et doit pouvoir englober diverses interventions telles que :
- les campagnes d’information à la population,
- la formation du personnel sanitaire ainsi qu’une implication de l’état,
- une bonne prise en charge des malades au niveau des centres de traitement de l’UB en collaboration avec les laboratoires régionaux et internationaux,
- la confirmation microbiologique des cas,
- la mise en place d’un suivi des malades en s’appuyant sur les structures déjà mises en place pour d’autres maladies,
- la mise à disposition des populations de sources d’eau potable (puits, pompes) qui par la même occasion permettront de limiter/diminuer d’autres affections liées à la consommation d’eau non potable,
- la poursuite des activités de recherche sur un éventuel vaccin ou une médication appropriée, ainsi que sur le réservoir de M. ulcerans afin de pouvoir mettre en place des stratégies de prévention de la maladie.
Doctorat en Sciences de la santé publique
info:eu-repo/semantics/nonPublished
Tuttle, Marie S. "Microbial Bioburden in Venous Leg Ulcers." Case Western Reserve University School of Graduate Studies / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=case1409912389.
Full textBooks on the topic "Ulcers"
Danijel, Erceg, and Milojeviæ Pero, eds. Ulcers: Causes, diagnosis, and treatment. Hauppauge, NY: Nova Science Publishers, 2009.
Find full textFenner, Louise. When digestive juices corrode, you've got an ulcer. Rockville, Md: Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, 1987.
Find full textRNT, Harper Peter RGN, ed. Leg ulcers. New York: Churchill Livingstone, 1997.
Find full textInc, Biomedical Business International, ed. Pressure ulcers. Santa Ana, CA: Biomedical Business International, 1990.
Find full text1927-, Bergan John J., and Shortell Cynthia K, eds. Venous ulcers. Amsterdam: Elsevier Academic Press, 2007.
Find full textHalpern, Georges M. Ulcer free!: Nature's safe & effective remedy for ulcers. Garden City Park, N.Y: Square One Publishers, 2004.
Find full textUnited States. Treatment of Pressure Ulcers Guideline Panel. Treating pressure ulcers. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1996.
Find full textUnited States. Treatment of Pressure Ulcers Guideline Panel. Treating pressure ulcers. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1996.
Find full textPatrias, Karen. Therapeutic endoscopy and bleeding ulcers: January 1980 through December 1988 : 491 citations. Bethesda, Md: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section, 1989.
Find full textE, Hernandez Daniel, Glavin Gary B, New York Academy of Sciences., University of Southern California. School of Medicine. Postgraduate Division., and International Conference: Biology of Stress Ulcers (1988 : Lake Arrowhead, Calif.), eds. Neurobiology of stress ulcers. New York, N.Y: New York Academy of Sciences, 1990.
Find full textBook chapters on the topic "Ulcers"
Theisler, Charles. "Ulcers—Pressure Ulcers/Decubitus Ulcers/Bedsores." In Adjuvant Medical Care, 348–49. New York: CRC Press, 2022. http://dx.doi.org/10.1201/b22898-339.
Full textHapp, Carrie. "Ulcers." In Encyclopedia of Ophthalmology, 1–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-35951-4_938-1.
Full textHapp, Carrie. "Ulcers." In Encyclopedia of Ophthalmology, 1864–66. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-540-69000-9_938.
Full textBeeckman, Dimitri, Nele Van Damme, Dorien De Meyer, and Karen Van den Bussche. "Pressure Ulcers." In Practical Issues in Geriatrics, 179–89. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-61997-2_19.
Full textPhilipone, Elizabeth, and Angela J. Yoon. "Oral Ulcers." In Oral Pathology in the Pediatric Patient, 33–60. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-44640-0_3.
Full textForciea, Mary Ann. "Pressure Ulcers." In Classic Papers in Geriatric Medicine with Current Commentaries, 145–51. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-428-5_14.
Full textMutasim, Diya F. "Leg Ulcers." In Practical Skin Pathology, 103–7. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-14729-1_22.
Full textJanson, Ben. "Corneal Ulcers." In Encyclopedia of Ophthalmology, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-35951-4_722-1.
Full textStreit, Markus, and Claudia Blazek. "Leg Ulcers." In European Handbook of Dermatological Treatments, 475–94. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45139-7_49.
Full textDhillon, Ramindar S., and James W. Fairley. "Mouth ulcers." In Multiple-choice Questions in Otolaryngology, 180. London: Palgrave Macmillan UK, 1989. http://dx.doi.org/10.1007/978-1-349-10805-3_266.
Full textConference papers on the topic "Ulcers"
Gierasimovič, Zita, and Zyta Kuzborska. "Assessment of the effectiveness of pressure ulcer care." In Biomdlore. VGTU Technika, 2016. http://dx.doi.org/10.3846/biomdlore.2016.04.
Full textBronneberg, Debbie, Lisette H. Cornelissen, Cees W. J. Oomens, Frank P. T. Baaijens, and Carlijn V. C. Bouten. "Cytokine and Chemokine Release Upon Sustained Mechanical Loading of the Epidermis." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176103.
Full textBuchón-Moragues, Fernando, David Sánchez-Jiménez, Jesús Palomar-Vázquez, and Guillermo Peris-Fajarnés. "PROCESAMIENTO AUTOMATIZADO DE MODELOS TRIDIMENSIONALES DE ÚLCERAS CUTÁNEAS." In 1st Congress in Geomatics Engineering. Valencia: Universitat Politècnica València, 2017. http://dx.doi.org/10.4995/cigeo2017.2017.6553.
Full textRusso, Lea, Mihir Gondhalekar, Sridhar Kota, and Benjamin Bassin. "A Device for Reducing Pressure Ulcers in Bedridden Patients Using Fiber Reinforced Elastomeric Enclosures (FREEs)." In ASME 2022 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2022. http://dx.doi.org/10.1115/imece2022-95255.
Full textBrakefield, Timothy, Thomas Burkhardt, Andrew Meehan, Gregory Nemunaitis, Mohamed Samir Hefzy, and Mehdi Pourazady. "Gurney Mattress Redesign." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80036.
Full textErdemir, Ahmet. "Role of Patient Specifics on Mechanical Risk and Load Relief During Support of Bony Prominences." In ASME 2013 Conference on Frontiers in Medical Devices: Applications of Computer Modeling and Simulation. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/fmd2013-16034.
Full textGeerligs, M., G. W. M. Peters, C. W. J. Oomens, P. Ackermans, and F. P. T. Baaijens. "Mechanical Behaviour of the Subcutaneous Fat Layer." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176364.
Full textManorama, Abinand, and Tamara Reid Bush. "Skin Perfusion, Arterial and Venous Blood Flow, and Soft Tissue Thickness in Relation to Pressure Ulcers." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14496.
Full textRotariu, Mariana, Iustina Condurache, Catalin Ionite, and Marius Turnea. "ANALYSIS AND FORECASTING OF BURULI ULCER DISEASE WITH ARIMA AND NARNN, A DIDACTIC TOOL APPROACH." In eLSE 2021. ADL Romania, 2021. http://dx.doi.org/10.12753/2066-026x-21-178.
Full textGhani, M. U., C. Sanina, and A. Fojas. "Penetrating Aortic Ulcers- A Cardiovascular Emergency." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3508.
Full textReports on the topic "Ulcers"
Barry, Charles, Mohamed Shefan Hameed, and Abilash Sathyanarayanan. Topical phenytoin use in diabetes related foot ulcers. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2023. http://dx.doi.org/10.37766/inplasy2024.1.0023.
Full textHeims, Jack. Re-evaluation Co-counseling and the Treatment of Peptic Ulcers. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.1753.
Full textGowenlock, Linda S. Evaluating Evidence-Based Intervention to Prevent Fall and Pressure Ulcers. Fort Belvoir, VA: Defense Technical Information Center, December 2011. http://dx.doi.org/10.21236/ada618679.
Full textOnikzeh, Parinaz, Afshin Heidari, Aida Kazemi, Parisa Najjariasl, Kamran Dalvandi, Hamidreza Sadeghsalehi, and Hadi Zamanian. 3D photography versus digital planimetry in wound measurement : a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0069.
Full textColleary, Colleen. An Investigation of Handedness and its Relationship to the Site of Contact Ulcers. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.2049.
Full textLiu, Hong-wei. Effect of intraoperative pressure ulcer preventive nursing on inflammatory markers in patients with high-risk pressure ulcers: A protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, April 2020. http://dx.doi.org/10.37766/inplasy2020.4.0029.
Full textFan, Weijing, Wenhui Li, Renyan Huang, Guobin Liu, Changgeng Fu, and Baozhong Yang. Hyperbaric Oxygen Therapy for treating chronic diabetic foot ulcers : an Overview of Systematic Reviews. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2021. http://dx.doi.org/10.37766/inplasy2021.1.0008.
Full textFan, Weijing, Xiao Yang, Feng Xv, Xiaoming Hu, Fang Guo, and Guobin Liu. Extracorporeal shockwave therapy for Diabetic foot ulcers Protocol for a systematic review and meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2020. http://dx.doi.org/10.37766/inplasy2020.11.0001.
Full textSprigle, Stephen, and Sharon Sonenblum. Pressure Relief Behaviors and Weight-Shifting Activities to Prevent Pressure Ulcers in Persons with SCI. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada616526.
Full textXu, ke, Guofeng Cai, Yanan Cui, Ziyin Gao, and Manchao Sun. The Meta-analysis of efficacy and safety of acupuncture in the treatment of stage Ⅱ-Ⅳ pressure ulcers. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2023. http://dx.doi.org/10.37766/inplasy2023.4.0033.
Full text